Common Stock, Shares, Outstanding of BIOMARIN PHARMACEUTICAL INC from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIOMARIN PHARMACEUTICAL INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 192,300,101, a 0.81% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 192,300,101 +1,538,752 +0.81% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 192,098,751 +1,544,833 +0.81% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 192,001,650 +1,646,133 +0.86% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 191,755,802 +1,979,225 +1% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 190,761,349 +2,163,195 +1.1% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 190,553,918 +2,214,436 +1.2% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 190,355,517 +2,203,822 +1.2% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 189,776,577 +2,175,471 +1.2% 31 Mar 2024 10-Q 26 Apr 2024 2024 Q1
Q4 2023 188,598,154 +2,347,435 +1.3% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 188,339,482 +2,515,229 +1.4% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 188,151,695 +2,699,241 +1.5% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 187,601,106 +2,699,342 +1.5% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 186,250,719 +2,338,205 +1.3% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 185,824,253 +2,256,829 +1.2% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 185,452,454 +2,130,634 +1.2% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 184,901,764 +2,231,150 +1.2% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 183,912,514 +2,171,515 +1.2% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 183,567,424 +2,075,080 +1.1% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 183,321,820 +2,173,488 +1.2% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 182,670,614 +1,908,645 +1.1% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 181,740,999 +1,902,885 +1.1% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 181,492,344 +1,887,963 +1.1% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 181,148,332 +1,715,016 +0.96% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 180,761,969 +1,728,865 +0.97% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 179,838,114 +1,585,160 +0.89% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 179,604,381 +1,701,593 +0.96% 30 Sep 2019 10-Q/A 04 Nov 2019 2019 Q3
Q2 2019 179,433,316 +1,925,181 +1.1% 30 Jun 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 179,033,104 +2,379,624 +1.3% 31 Mar 2019 10-Q 29 Apr 2019 2019 Q1
Q4 2018 178,252,954 +2,409,205 +1.4% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 177,902,788 +2,407,438 +1.4% 30 Sep 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 177,508,135 +2,259,288 +1.3% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 176,653,480 +3,349,287 +1.9% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 175,843,749 +3,196,161 +1.9% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 175,495,350 +3,797,701 +2.2% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 175,248,847 +11,966,766 +7.3% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 173,304,193 +11,061,177 +6.8% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 172,647,588 +11,121,544 +6.9% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q3 2016 171,697,649 +10,471,239 +6.5% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 163,282,081 +2,273,567 +1.4% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 162,243,016 +1,960,703 +1.2% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 161,526,044 +12,432,397 +8.3% 31 Dec 2015 10-K 27 Feb 2017 2016 FY
Q3 2015 161,226,410 +13,792,459 +9.4% 30 Sep 2015 10-Q 02 Nov 2015 2015 Q3
Q2 2015 161,008,514 +13,940,564 +9.5% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 160,282,313 +14,543,917 +10% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 149,093,647 +5,629,979 +3.9% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 147,433,951 +5,232,956 +3.7% 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 147,067,950 +7,017,941 +5% 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 145,738,396 +6,865,189 +4.9% 31 Mar 2014 10-Q 02 May 2014 2014 Q1
Q4 2013 143,463,668 +17,654,506 +14% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 142,200,995 +18,410,845 +15% 30 Sep 2013 10-Q 28 Oct 2013 2013 Q3
Q2 2013 140,050,009 +16,814,127 +14% 30 Jun 2013 10-Q 29 Jul 2013 2013 Q2
Q1 2013 138,873,207 +23,191,382 +20% 31 Mar 2013 10-Q 29 Apr 2013 2013 Q1
Q4 2012 125,809,162 +11,019,430 +9.6% 31 Dec 2012 10-K 26 Feb 2014 2013 FY
Q3 2012 123,790,150 +9,640,370 +8.4% 30 Sep 2012 10-Q 29 Oct 2012 2012 Q3
Q2 2012 123,235,882 +11,671,082 +10% 30 Jun 2012 10-Q 02 Aug 2012 2012 Q2
Q1 2012 115,681,825 +4,808,306 +4.3% 31 Mar 2012 10-Q 30 Apr 2012 2012 Q1
Q4 2011 114,789,732 +4,155,267 +3.8% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 114,149,780 +11,685,271 +11% 30 Sep 2011 10-Q 31 Oct 2011 2011 Q3
Q2 2011 111,564,800 +9,548,022 +9.4% 30 Jun 2011 10-Q 01 Aug 2011 2011 Q2
Q1 2011 110,873,519 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 110,634,465 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 102,464,509 30 Sep 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 102,016,778 30 Jun 2010 10-Q 04 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.